For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Axon Therapies, Inc.

USPTO Granted Patents = 15

EPO Patents = 4

Forward Citations = 103

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Howard Levin (13 out of 52 patents)

Mark Gelfand (11 out of 216 patents)

Zoar Jacob Engelman (10 out of 15 patents)

4. Dorin Panescu (6 out of 225 patents)

5. Mark S Leung (6 out of 32 patents)

6. Pajhand Iranitalab (4 out of 7 patents)

7. Casey Andrew Miller (4 out of 5 patents)

8. Thomas Ryan McGrath (4 out of 5 patents)

9. Manuel Arzadon Javier, Jr (4 out of 10 patents)

10. Anisha Bapna (4 out of 4 patents)

11. Andrew H Wu (4 out of 56 patents)

12. Anne Marie Ahonen (2 out of 2 patents)

13. Nicholas C VanDillen (2 out of 2 patents)

14. Tamara Colette Baynham (1 out of 50 patents)

15. Manuel Arzadon Javier (0 patent)

15 patents: Sort by Forward Citations

1. 12349966 - Methods and devices for endovascular ablation of a splanchnic nerve (2025-07-08),

2. 11864826 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2024-01-09),

3. 11844569 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-12-19),

4. 11806073 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-11-07),

5. 11801092 - Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation (2023-10-31),

6. 11751939 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-09-12),

7. 11712296 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-08-01),

8. 11504185 - Methods and devices for endovascular ablation of a splanchnic nerve (2022-11-22),

9. 11413090 - Methods and devices for endovascular ablation of a splanchnic nerve (2022-08-16),

10. 11376066 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2022-07-05),

11. 11154354 - Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation (2021-10-26),

12. 10912610 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2021-02-09),

13. 10561461 - Methods and devices for endovascular ablation of a splanchnic nerve (2020-02-18),

14. 10376308 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2019-08-13),

15. 10207110 - Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve (2019-02-19),

Company Overview

Axon Therapies, Inc. is a biotechnology company based in New York, specializing in the development of innovative therapies for neurological disorders. The organization focuses on advancing treatments that target the underlying mechanisms of these conditions, leveraging cutting-edge research in neurobiology and pharmacology. With a commitment to improving patient outcomes, Axon Therapies aims to address unmet medical needs through its proprietary technologies and collaborative research initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#496 in New York, NY

#1,220 in New York

#21,068 in US

#39,959 in the World

New York, NY, United States of America

Axon Therapies, Inc.

Forward Citations = 103

14 inventors:

Howard Levin (13 out of 52 patents)

Mark Gelfand (11 out of 216 patents)

Zoar Jacob Engelman (10 out of 15 patents)

4. Dorin Panescu (6 out of 225 patents)

5. Mark S Leung (6 out of 32 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axon Therapies, Inc.. Retrieved from https://idiyas.com/company/axon-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…